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Overexpression of Mcl-1 exacerbates lymphocyte
accumulation and autoimmune kidney disease in
lpr mice
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Cell death by apoptosis has a critical role during embryonic development and in maintaining tissue homeostasis. In mammals,
there are two converging apoptosis pathways: the ‘extrinsic’ pathway, which is triggered by engagement of cell surface ‘death
receptors’ such as Fas/APO-1; and the ‘intrinsic’ pathway, which is triggered by diverse cellular stresses, and is regulated by pro-
survival and pro-apoptotic members of the Bcl-2 family of proteins. Pro-survival Mcl-1, which can block activation of the pro-
apoptotic proteins, Bax and Bak, appears critical for the survival and maintenance of multiple haemopoietic cell types. To
investigate the impact on haemopoiesis of simultaneously inhibiting both apoptosis pathways, we introduced the vavP-Mcl-1
transgene, which causes overexpression of Mcl-1 protein in all haemopoietic lineages, into Faslpr/lpr mice, which lack functional
Fas and are prone to autoimmunity. The combined mutations had a modest impact on myelopoiesis, primarily an increase in the
macrophage/monocyte population in Mcl-1tg/lpr mice compared with lpr or Mcl-1tg mice. The impact on lymphopoiesis was
striking, with a marked elevation in all major lymphoid subsets, including the non-conventional double-negative (DN) T cells
(TCRβ+CD4–CD8–B220+) characteristic of Faslpr/lprmice. Of note, the onset of autoimmunity was markedly accelerated inMcl-1tg/lpr
mice compared with lpr mice, and this was preceded by an increase in immunoglobulin (Ig)-producing cells and circulating
autoantibodies. This degree of impact was surprising, given the relatively mild phenotype conferred by the vavP-Mcl-1 transgene
by itself: a two- to threefold elevation of peripheral B and T cells, no significant increase in the non-conventional DN T-cell
population and no autoimmune disease. Comparison of the phenotype with that of other susceptible mice suggests that the
development of autoimmune disease in Mcl-1tg/lpr mice may be influenced not only by Ig-producing cells but also other
haemopoietic cell types.
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Cell death by apoptosis has a critical role in maintaining tissue
homeostasis and its inhibition can result in autoimmunity and
tumour development (for reviews, see Strasser et al.1,2 and
Moldoveanu et al.3). Apoptosis is executed by certain
aspartate-specific cysteine proteases of the caspase family,
which are constitutively produced in zymogen form. In
mammals, there are two distinct pathways for the activation
of such caspases. The ‘extrinsic’ pathway is triggered by
ligation of ‘death receptors’ of the tumour necrosis factor
receptor family, such as Fas, on the plasma membrane.
Multimerization of Fas by the trimeric Fas ligand (FasL) results
in the formation of a death-inducing signalling complex
(DISC),4 through recruitment of the FADD adaptor protein
and pro-caspase-8 (and, in humans, also pro-caspase-10),
which results in auto-activation of this ‘initiator’ caspase. In
contrast, the ‘intrinsic’ pathway, which is triggered in response
to diverse intracellular stresses (e.g., cytokine deprivation,
DNA damage) and is regulated by the Bcl-2 protein family,
results in permeabilization of the mitochondrial outer mem-
brane (MOM) and release of cytochrome c into the cytoplasm
where it serves as a co-factor for the auto-activation of pro-
caspase-9 on the apoptosome. For each pathway, activation of
the ‘initiator’ caspase (−8 or − 9) results in the cleavage and
activation of several downstream ‘effector’ caspases (−3, − 6
and −7), which in turn provoke dismantling of the cell by
cleaving scores of vital proteins. The two apoptosis pathways
act largely independently although, under certain conditions,
Fas signalling results in caspase-8 cleavage of Bid, a pro-
apoptotic member of the Bcl-2 family (see below), which then
amplifies the apoptosis signal by bringing the intrinsic pathway
into play.
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The Bcl-2 protein family comprises nearly a score of pro-
and anti-apoptotic proteins, which together operate as a cell
life–death switch.1,3,5,6 Bcl-2 and its closest homologues
(Bcl-xL, Bcl-w, Mcl-1 and A1/BFL-1) promote MOM integrity,
and hence cell survival, by inhibiting activation of very similar
but pro-apoptotic homologues, Bax and Bak. Stress, however,
upregulates a further group of more distant pro-apoptotic
relatives, known as Bcl-2 homology domain 3 (BH3)-only
proteins, which bind avidly to the pro-survival Bcl-2-like
proteins, thereby neutralizing their capacity to inhibit Bax
and Bak. Certain BH3-only proteins (e.g., Bim, Bid and Puma)
can facilitate activation of Bax and Bak, by directly inducing
their conformational change and homo-dimerization in the
MOM.7,8 Subsequent homo-oligomerization of the Bax and/or
Bak dimers leads to MOM permeabilization and caspase-9
activation (see above). A recent multi-gene editing study
suggests that, in the absence of pro-survival proteins,
BH3-only proteins are not required for activation of
Bax/Bak,9 presumably because these proteins are stochas-
tically unstable in the membrane.
Individual pro-survival Bcl-2-like proteins vary in abundance in
different haemopoietic cell types and gene knockout studies
have revealed differential dependencies; for example, whereas
Bcl-2 primarily sustains the survival of mature lymphoid cells,10
Mcl-1 is critical for the survival and maintenance of multiple
haemopoietic cell types including haemopoietic stem/progenitor
cells,11 B and T lymphocytes,12–14 neutrophils and activated
macrophages,15,16 and dendritic cells.17 Accordingly, reduced
Mcl-1 levels severely compromise recovery of haemopoiesis
following myeloablative challenge or bone marrow
transplantation.18
Mcl-1 is the most divergent and short-lived pro-survival
protein and has a distinctive interaction profile with its pro-
apoptotic relatives. Like all other pro-survival relatives, it binds
the BH3-only proteins Bim, tBid and Puma with high affinity.
However, like A1/BFL-1, it also binds strongly to Noxa but fails
to bind to Bad, whereas the opposite holds for Bcl-2,
Bcl-xL and Bcl-w.
19,20 Furthermore, Mcl-1 restrains activation
of both Bak and Bax, whereas Bcl-2 only restrains Bax.21–23
Unusually, Mcl-1 is found not only on the MOM but also within
the mitochondrial matrix,24 where it is proposed to regulate
mitochondrial bioenergetics.
Genetic studies have established that both the extrinsic and
intrinsic apoptosis pathways have a major role in regulating
immunity.2,25,26 Thus, Faslpr/lpr (hereafter lpr) mice,27 which
have a non-functional Fas death receptor,28 exhibit severely
perturbed lymphopoiesis, developing progressive lymphade-
nopathy, splenomegaly and autoimmune syndromes (such as
glomerulonephritis (GN)) that vary in severity with genetic
background;27 and humans with Fas mutations develop an
autoimmune lymphoproliferative syndrome termed ALPS.29,30
Inhibition of the intrinsic pathway via transgenic (tg) over-
expression of Bcl-2 results primarily in lymphoid hyperplasia,
accompanied by elevated and prolonged antibody responses
and, in some situations, autoimmunity.31–34 Early studies of
BCL-2 tg/lpr35 and bim− /−/lpr mice36 indicated that simulta-
neous inhibition of both pathways is synergistic.
In view of the importance of Mcl-1 in regulating haemopoi-
esis (see above), we have been investigating the impact of its
overexpression using a vavP-Mcl-1 transgene, which is
expressed in all haemopoietic cell lineages.37 We reported
previously that vavP-Mcl-1 tg mice develop excess mature B
and T cells but maintain relatively normal numbers of myeloid
cells and lack an autoimmune phenotype.37 In this study, we
have introduced the vavP-Mcl-1 transgene into lpr mice, to
investigate the impact of combined loss of Fas and over-
expression of Mcl-1. We found clear evidence of synergy:
marked perturbation of lymphopoiesis and a lesser, but
significant, impact on myelopoiesis. Of note, autoimmune
GNwasmarkedly accelerated in lprmice expressing the vavP-
Mcl-1 transgene.
Results
Overexpression of Mcl-1 markedly exacerbates the lpr
phenotype. VavP-Mcl-1 tg (hereafter Mcl-1tg) mice were
crossed with Faslpr/lpr (hereafter lpr) mice to generate vavP-Mcl-
1tg/Faslpr/lpr (hereafter Mcl-1tg/lpr) mice. All mice were on a
C57BL/6 background, in which the lpr autoimmune phenotype
is less severe than on the autoimmune-prone MRL
background.27 In vitro tests on CD4+CD8+ (double positive
(DP)) thymocytes showed that, as expected, those from Mcl-
1tg/lpr mice were robustly resistant to cell death induced via
both the intrinsic and extrinsic apoptosis pathways (Figure 1a).
Thus, Mcl-1tg/lpr DP thymocytes were refractory to killing
induced by the DNA-damaging agent etoposide as well as FasL
(Fc-FasL), whereas those from Mcl-1tg mice were resistant to
etoposide but sensitive to FasL and those from lpr mice were
profoundly resistant to FasL but sensitive to etoposide.
Endogenous and tg Mcl-1 protein was readily apparent in
both lymphoid and myeloid cells of Mcl-1tg and Mcl-1tg/lpr
mice (Figures 1b-h and Campbell et al.37). The level of
endogenous Mcl-1 protein was comparable in all cell types
analyzed and tg Mcl-1 (upper band) was present at equivalent
or higher levels (Supplementary Figure S1a).
The development of lymphadenopathy and splenomegaly
was both accelerated and accentuated in Mcl-1tg/lpr mice
compared with lpr mice (Figure 2). The differential was
apparent as early as 8 weeks of age and became more
exaggerated with time (Figure 2b and Supplementary Tables
S1-3). By 21 weeks, the mean spleen cellularity in Mcl-1tg/lpr
mice was 12-fold higher than in wild type (WT) mice, whereas
that in lpr and Mcl-1tg mice was 2.1- and 1.7-fold higher,
respectively.
The blood and haemopoietic tissues were analyzed by
immunostaining and flow cytometry (Supplementary Figures
S2 and S3) to delineate which cell populations were affected.
Myelopoiesis was relatively normal in both lpr and Mcl-1tg
mice, as reported earlier.37–39 However, macrophages
(Mac1+Gr1−) were significantly elevated in the spleens of
Mcl-1tg/lpr mice compared with either lpr or Mcl-1tg mice,
being evident as early as 14 weeks and becoming even
more prominent with increasing age, whereas granulocytes
(Mac1+Gr1+) were only modestly elevated by 21 weeks
(Figure 3a left panel). Ter119+ erythroid cells were
also significantly elevated in the spleen (Supplementary
Tables S1-3). In the blood, increased numbers of granulocytes
andmacrophages were apparent by 21 weeks (Figure 3a right
panel) but no major differences were apparent in the bone
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marrow (Supplementary Tables S1-3). Thus, although over-
expression of Mcl-1 perturbs myelopoiesis in lpr mice, the
impact, while significant, is relatively modest.
In contrast, there was a profound impact on lymphopoiesis.
From an early age, both T lymphoid (Figure 3b) and B
lymphoid populations (including plasma cells) (Figure 3c,
Figure 1 Mcl-1 transgene expression in lprmice. (a) Lymphocytes fromMcl-1tg/lprmice are resistant to apoptosis triggered through either the intrinsic or extrinsic pathways.
Sorted CD4+CD8+ DP thymocytes from WT, Mcl-1tg, lpr and Mcl-1tg/lpr mice were cultured in vitro at 50 × 103 cells in 100 μl for 48 h in medium alone (left panel), medium
containing 32 ng/ml Fc-FasL (centre panel) or 1 μg/ml etoposide (right panel). Viability was determined as the proportion of cells negative for PI uptake and annexin V surface
staining, normalized to viability at 0 h. Viability following treatment with Fc-FasL and etoposide are given relative to untreated cells to show stimulus-specific apoptosis. Data
represent average response of three independent mice per genotype± S.E.M. (b-h) Expression of endogenous and tg Mcl-1 protein in diverse haemopoietic cell types. Western
blot analysis of lysates of (b) CD4+ T cells (CD4+CD8–), (c) CD8+ T cells (CD4–CD8+) and (d) unusual T cells (TCRβ+CD4–CD8–B220+) sorted from spleen; (e) Pre B cells
(CD19+IgM–IgD–) sorted from bone marrow; (f) B cells (CD19+) sorted from spleen; (g) granulocytes (Mac1+Gr1+) and (h) macrophages (Mac1+Gr1–) sorted from bone marrow.
Genotypes and mouse identification numbers are indicated. Lysates prepared from whole spleen of lprmouse #641 andMcl-1tg/lprmouse #637 were run on each gel to facilitate
cross-comparison between different cell types. The solid line indicates electronic removal of two lanes. Each gel was probed with anti-Mcl-1 and anti-FLAG antibodies; because of
the presence of the FLAG epitope tag, tg Mcl-1 protein is larger than endogenous Mcl-1. Representative blots of n= 1–4 experimental replicates. Refer to Supplementary
Figure S1 for quantification of blots; sorted myeloid cells and spleen cells appear to contain degraded Mcl-1 making interpretation of relative levels of endogenous and tg Mcl-1
ambiguous
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Supplementary Figures S3 and S5) were significantly
elevated in Mcl-1tg/lpr mice compared with lpr or Mcl-1tg
mice (see also Supplementary Tables S1-3). The lymphade-
nopathy in lpr mice primarily reflects large numbers of non-
malignant non-conventional double-negative (DN) T cells
(TCRβ+CD4–CD8−B220+), which are thought to be derived
from activated CD8+ T cells that have failed to die because of
defective FasL/Fas-mediated apoptosis and have lost CD8 co-
receptor expression (see Fortner et al.40). Mcl-1 overexpres-
sion provoked a marked increase in this population: by
21 weeks, an increase of 20- and 25-fold in the spleen and
lymph nodes, respectively, was evident in Mcl-1tg/lpr mice
compared with lpr mice (Figure 3b right panel and
Supplementary Table S3). The inference is that both apoptosis
pathways control these cells.
Overexpression of Mcl-1 accelerates the morbidity of lpr
mice. Cohorts of mice were aged to investigate whether
overexpression of Mcl-1 enhanced the pathological conse-
quences of the lpr mutation. Mice carrying both mutations
became terminally ill prematurely, with a significant reduction
in median survival (143 days compared with 341 days, Mcl-
1tg/lpr versus lpr Po0.0001; Figure 4a). Many Mcl-1tg/lpr
mice had to be killed because of excessive weight loss and/or
breathing difficulties caused by the severe lymphadenopathy,
particularly the massive increase in the size of the cervical
and mediastinal lymph nodes. Although several factors may
have contributed to the overall morbidity (see further below),
the presence of blood in the urine (haematuria) in approxi-
mately 75% of the Mcl-1tg/lpr and lpr mice suggested that
kidney damage was also a contributing cause.
Autopsy of sick mice revealed splenomegaly and lympha-
denopathy, elevated peripheral white blood cells and reduced
platelets, each of these phenotypes being of significantly
greater severity in Mcl-1tg/lpr than lpr mice (Figure 4b). In
addition, sickmice had one or more of the following symptoms:
pale kidneys, mottled liver, mottled lungs and sialitis (inflam-
mation of the submandibular gland), primarily due to lympho-
cyte infiltration of these organs (Supplementary Figure S4 and
data not shown). Although the extent of infiltration and the
range of organs affected varied between mice of the same
genotype, sickMcl-1tg/lprmice appeared to be more severely
affected than lpr mice.
Kidney sections were scored for GN, characterized by
glomerular hypercellularity and leukocyte infiltration
(Supplementary Figure S4). Although the proportions of mice
with severe GN (pathological score ⩾ 2) (Figure 4c) or
haematuria (Figure 4d) was comparable for sick lpr and sick
Mcl-1tg/lpr mice, the latter showed a significantly accelerated
onset of severe GN (lpr versus Mcl-1tg/lpr Po0.0001)
(Figure 4e).
Polyclonal hypergammaglobulinaemia is amajor phenotype
of autoimmune disease-prone humans and mice. In lpr mice,
the elevated serum immunoglobulin (Ig) is associated with the
deposition of Ig complexes in the renal glomeruli, which is a
contributing factor in the development of severe GN.27 At
14 weeks of age, before GN onset, significantly elevated levels
of IgG1, IgG2a and IgG3 were observed in lpr mice, whereas
serum Ig levels in Mcl-1tg mice were comparable to those in
WT mice (Figure 5a). Notably Mcl-1tg/lpr mice had signifi-
cantly higher Ig levels than lpr mice, particularly IgG1 and
IgG2a, which are complement-fixing antibodies and can form
immune complex deposits, and IgA, which is elevated in
Figure 2 Enhanced splenomegaly and lymphadenopathy in Mcl-1tg/lpr mice. (a) Lymph nodes (from left to right, inguinal, axillary and brachial) and spleen dissected from
14-week WT,Mcl-1tg, lpr, andMcl-1tg/lprmice. (b) Total cellularity of lymph nodes (inguinal, axillary and brachial), spleen and peripheral blood of WT (white),Mcl-1tg (light grey),
lpr (dark grey) andMcl-1tg/lpr (black) mice aged 8, 14 and 21 weeks. An equal proportion of male and female mice were used and no difference was observed between genders.
Data represent the average of 7–12 individual mice±S.E.M. *Po0.05, **Po0.01, ***Po0.001, calculated by Student’s T-test with Welch’s correction. Refer to Supplementary
Tables S1-3 for complete data
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certain forms of renal disease. Consistent with these findings,
splenic plasma cells (B220−CD138+) were elevated in
Mcl-1tg/lpr mice compared with lpr mice (Supplementary
Figure S5, Supplementary Table S2). ELISPOT (enzyme-
linked immunoSpot) enumeration (Figure 5b) also indicated
that Mcl-1tg/lpr mice had elevated IgM- and IgG-producing
cells in the spleen and increased numbers of IgG-producing
cells in the bone marrow compared with WT mice.
Figure 3 Enhanced splenomegaly and lymphadenopathy in Mcl-1tg/lpr mice is primarily due to elevated lymphoid populations. (a) Enumeration of myeloid populations
(Mac1+Gr1+ and Mac1+Gr1– cells) in the spleen and peripheral blood of mice aged 8, 14 and 21 weeks. Data represent the average of 5-12 individual mice± S.E.M. (b)
Enumeration of conventional T cells (CD4+CD8− and CD4−CD8+) and non-conventional DN T cells (TCRβ+CD4−CD8–B220+); and (c) B lymphoid populations (B220+IgM−IgD−,
B220+IgM+IgD−and B220+IgM+IgD+) in lymph nodes (inguinal, axillary and brachial lymph nodes) of mice aged 8, 14 and 21 weeks. Data represent average of 6–12 individual
mice± S.E.M. *Po0.05, **Po0.01, ***Po0.001, calculated by Student’s T-test with Welch’s correction. An equal proportion of male and female mice were studied, with no
gender differences being observed. Refer to Supplementary Tables S1-3 for complete data and Supplementary Figure S2 for gating strategies. Analysis of the B lymphoid
compartment using CD19 as a marker rather than B220 revealed that the TCRβ−B220+IgM−IgD– population enumerated in (c) contained a number of non-conventional DN
T cells with low TCRβ expression. Thus, although B lymphoid cell numbers were indeed elevated in Mcl-1tg/lpr mice compared with lpr mice, the actual increase was less than it
had appeared using B220 as the marker: ~ 3-fold at 14 weeks rather than ~ 6-fold (see Supplementary Figure S3 and Supplementary Table S2)
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Furthermore, the number of bone marrow-resident IgG-
producing cells was significantly higher in Mcl-1tg/lpr than
lpr mice.
Next, we analyzed the kidneys of sick lpr and Mcl-1tg/lpr
mice to ascertain whether the elevated serum Ig was
associated with immune complex deposition in the renal
glomeruli. IgG-, IgM- and IgA-containing immune complex
deposits were detectable in the glomerular capillary loops in a
proportion of these mice (Figure 5c and Supplementary
Figure S6). However, no difference was apparent between
the two genotypes in the severity or proportions of mice having
this phenotype (Figure 5d). Although all lpr and Mcl-1tg/lpr
mice had immune complex deposits on the mesangial cells,
most commonly consisting of IgM, as did some aged WTand
Mcl-1tg mice (Figures 5c, d and Supplementary Figure S6),
neither mesangial immune complex deposition nor IgM
immune complexes is usually associated with glomeruli
destruction in human systemic lupus erythematosus
(SLE)-associated GN.41 These data, together with the clinical
score (Figures 4c and e), suggest that both lpr andMcl-1tg/lpr
mice develop comparable kidney disease, but the Mcl-1tg/lpr
mice experience an accelerated onset (Figure 4e).
Overexpression of Mcl-1 in lpr mice is associated with
increased levels of anti-nuclear autoantibodies. Elevated
serum anti-nuclear autoantibodies (ANAs) are one of the
Figure 4 Overexpression of Mcl-1 increases the severity and accelerates the onset of the lpr autoimmune disease phenotype. (a) Kaplan–Meier plot showing overall survival
of lpr (grey, n= 77) versus Mcl-1tg/lpr (black, n= 89) mice. The lifespan ofMcl-1tg/lprmice is significantly reduced compared with lprmice (Po0.0001, calculated using Mantle–
Cox test), median survival being 143 and 341 days, respectively. An equal number of male and female mice were aged for each genotype; no gender difference was observed.
(b) Haemopoietic analysis of sick lpr (grey, n= 28–30) and Mcl-1tg/lpr (black, n= 25–32) mice, including weights of lymph node (inguinal, axillary and brachial) and spleen and
enumeration of circulating white blood cells (WBC) and platelets. Data points represent individual mice with mean± S.E.M. indicated. **Po0.01, ***Po0.001, calculated by
Student’s T-test with Welch’s correction. Significance for spleen weights is indicated with and without two outlier lpr mice (black circled points). (c and d) Renal pathology,
assessed by (c) GN pathology scoring (score 0–4) and (d) haematuria (scored out of 4) in sick lpr (grey; n= 26–41) and Mcl-1tg/lpr (black; n= 34–43) mice. Data points
represent individual mice with mean± S.E.M. indicated. (e) Kaplan–Meier plot of the incidence of severe GN (clinical score⩾ 2) in sick lpr (grey, n= 26) versus sick Mcl-1tg/lpr
(black, n= 33) mice, Po0.0001 (Mantle–Cox test)
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diagnostic criteria for SLE and certain other autoimmune
diseases in humans and mice, including the lpr strain. To
ascertain whether the sick mice had developed autoimmune
disease, their sera were analyzed by enzyme-linked immu-
nosorbent assay (ELISA) for the presence of ANAs directed
to ssDNA or dsDNA. We found that sick Mcl-1tg/lpr mice had
higher mean IgM ANA levels than sick lpr mice (Figure 6a).
Pertinently, the sera from healthy 21-week-old Mcl-1tg/lpr
mice contained elevated ANAs (both IgM and IgG) compared
with age-matched Mcl-1tg and WT mice and elevated IgG
ANAs compared with age-matched lpr mice (Figure 6a). As
previously reported,37 Mcl-1tg mice did not have significantly
elevated ANA levels.
ANAs can also be detected by staining of fixed mitotic
HepG2 cells. We found that the ANA levels (immunofluor-
escent brightness, scored 0–3) were significantly elevated in
sera of sickMcl-1tg/lpr comparedwith sick lprmice (Figures 6b
and c), validating our ELISA assays. Two distinct staining
patterns were observed: homogenous staining of the nucleus
(denoted nuclear staining) or staining primarily around the
nuclear membrane and excluding the nucleus (denoted
peripheral staining). A greater proportion of nuclear staining
was observed for the Mcl-1tg/lpr sera compared with the
lpr sera, which produced primarily peripheral or undetectable
staining (Figure 6d), however, both patterns are associated
with SLE. In conclusion, these data show that overexpression
of Mcl-1 increases the levels of autoantibodies in lpr mice
(Figure 6) and, importantly, this can be observed before GN
pathology (Figure 6a).
Overexpression of Mcl-1 does not enhance malignant
transformation in lpr mice. As Mcl-1tg mice develop
lymphoid tumours with age (median onset, 531 days),37 and
lpr mice show a low, albeit significant, incidence of
plasmacytomas and T lymphomas at advanced age,42 sick
Mcl-1tg/lpr mice were assessed to see if malignant cells were
contributing to morbidity. Splenocytes (2 × 106) from sick
lpr (aged 397–463 days) and sick Mcl-1tg/lpr (aged
152–227 days) mice were each transplanted into non-
irradiated syngeneic C57BL/6 mice, which were then
monitored for survival (Supplementary Table S4). All recipi-
ents remained healthy until termination of the experiment
(421 days), indicating that frankly malignant cells were not
present at measurable frequency in any of the donor spleens.
Discussion
The intrinsic and extrinsic apoptotic pathways each have
critical roles in regulating homeostasis of haemopoietic
tissues.2,25,26 The study undertaken here has shown that
(modest) overexpression of Mcl-1 via the haemopoietic cell-
specific vavP-Mcl-1 transgene markedly exacerbates and
accelerates the lpr phenotype. The progressive splenomegaly
and lymphadenopathy displayed by lpr mice was far more
severe in Mcl-1tg/lpr littermates (Figure 2a). Most of this can
be attributed to an expansion of lymphoid (see further below)
rather than myeloid cell populations, although the numbers of
granulocytes, macrophages and immature erythroid cells
were clearly elevated by 21 weeks (particularly in the spleen)
(Figure 3, Supplementary Figure S3 and Supplementary
Tables S1-S3). Amore severe granulocytic phenotype had been
anticipated, given the rapid turnover of granulocytes,43 their
sensitivity to FasL/Fas-induced apoptosis in vitro,38,44–47 genetic
evidence that Mcl-1 is critical for granulocyte survival in vivo15
and in vitro indications of an interplay between the extrinsic and
intrinsic apoptotic pathways in regulating neutrophil survival
in vitro.48 However, as the transgene is not as highly expressed
in granulocytes as in other cell types (Figure 1g and
Supplementary Figure S1b), the absence of a marked
granulocytic phenotype may be due to insufficient overexpres-
sion. Alternatively, homeostasis of myeloid cells may primarily
involve mechanisms other than the stress and FasL/Fas
pathways. Indeed, it seems likely that multiple control processes
have evolved to ensure the short lifespan of granulocytes, in
order to provide a critical check on the inflammatory response.
In contrast to the modest effect observed on myelopoiesis,
overexpression of Mcl-1 greatly increased lymphocyte num-
bers in lpr mice, primarily in the spleen and peripheral lymph
nodes. Already evident at 8 weeks, the lympho-accumulation
became even more prominent with age. All major subsets of
lymphoid cells (B and T) were elevated, most prominently the
non-conventional DN T-cell (TCRβ+CD4–CD8–B220+) popula-
tion, a defining characteristic of lpr mice and human ALPS
patients.2 Many investigators consider these unconventional
T cells represent previously activated CD8+ T cells that have
failed to die (see Fortner et al.40), although this view has been
challenged recently with the suggestion that they expand from
a rare sub-population in secondary lymphoid organs that are
normally removed by FasL/Fas-mediated apoptosis.49
Irrespective of their origin, our data suggest that the intrinsic
apoptosis pathway limits the expansion of this population.
Morbidity was greatly accelerated in Mcl-1tg/lpr mice
compared with lpr mice, the median survival being 143 and
341 days, respectively (Figure 4a). The Mcl-1tg/lpr mice had
increased lymphadenopathy, splenomegaly, blood cellularity
and thrombocytopaenia and their serum Ig and ANA levels
were also elevated. Although the clinical severity of the GN,
which is caused by deposition of immune complexeswithin the
mesangium and glomerular capillary loops, was comparable
in sick lpr andMcl-1tg/lprmice (Figures 5c and d), the onset of
GN pathology was significantly accelerated in the latter
(Figure 4e). This degree of impact was surprising, given the
relatively mild phenotype conferred by the vavP-Mcl-1
transgene by itself: a two- to threefold elevation of peripheral
B and T cells, no increase in the unusual DN T-cell population
and no autoimmune disease (Campbell et al.37 and data
presented here, Figures 2–6). Overall, our findings suggest
that the marked acceleration of morbidity inMcl-1tg/lprmice is
due to a combination of the increased severity of the lympho-
accumulation disease (causing respiratory distress) and the
accelerated onset of GN (elevated serum Ig levels, auto-
antibodies and lymphoid infiltration of renal glomeruli). The
strong synergy implies that the (B and T) lymphoid cells that
accumulate when Fas-induced apoptosis fails can still die in
response to stress signals, limiting cytokines being a likely
source of such stress. More specifically, our data indicate that
the Fas and the mitochondrial apoptosis pathways synergize
in suppressing autoimmunity.
This report complements previous genetic studies showing
that inhibition of the intrinsic apoptosis pathway can
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exacerbate the lpr phenotype.35,36,50,51 Early crosses of lpr
and BCL-2 tg mice (on a mixed C57BL/6 ×SJL background)
showed that overexpression of BCL-2 can greatly enhance
splenomegaly and lymphadenopathy, primarily due to the
accumulation of 'unusual' DN T cells.35,52 Combined loss of
both Fas and the BH3-only protein Bim (on a C57BL/6
background) also provoked this phenotype,36,40,50 accompa-
nied by accumulation of granulocytes and activated macro-
phages in the spleen and severe GN.50,53 Interestingly, the
median survival of ourMcl-1tg/lprmice is comparable to that of
the Bim+/− /lpr mice,36 indicating that the overexpression of
Mcl-1 had less impact than complete loss of Bim. Numerous
studies have identified Bim as being vital for inducing
apoptosis during development lymphocyte and
selection.54–58 Presumably the level of Mcl-1 overexpression
achieved via the vavP-Mcl-1 transgene was insufficient to
neutralize all Bim triggered in vivo.
To put this study into context, it is important to note that
inhibition of the intrinsic apoptosis pathway can lead to
autoimmune disease even in the absence of mutation of FasL
or Fas. Thus, one of our BCL-2 tg mouse lines, Eμ-BCL-2-22,
which was produced on a mixed C57BL/6 x SJL background,
was found to develop ANAs and immune complex GN.32 This
phenotype was dependent on the B lymphoid expression of
the Eμ-BCL-2-22 transgene because a contemporaneous line
having T-cell restricted expression (Eμ-BCL-2-25) did not
develop autoimmune pathology.59 It was also dependent on
(unknown) SJL-encoded traits because when Eμ-BCL-2-22
mice were subsequently backcrossed to a C57BL/6 back-
ground, the autoimmune phenotype disappeared,59 despite
the B lymphoid hyperplasia remaining prominent (see Table 1
in Egle et al.34). More recently, irradiated C57BL/6 mice
reconstituted with haemopoietic stem and progenitor cells that
are defective in the intrinsic apoptotic pathway, viz foetal liver
cells from C57BL/6 vavP-BCL-2, Bax− /−/Bak− /− or Bak − /−
(but not Bax− /−) mice, were shown to develop fatal SLE-like
GN and multi-organ autoimmune disease associated with
polyclonal hypergammaglobulinaemia and ANAs.60 Further-
more, C57BL/6 mice with pan-haemopoietic tg expression of
BCL-2 (vavP-BCL-2 mice) are highly susceptible to auto-
immune kidney disease (25% by 40 weeks of age).34
Pertinently, in addition to elevated B lymphoid populations,
C57BL/6 vavP-BCL-2 tg mice33,34 have elevated myeloid and
T lymphoid populations, as do the Mcl-1tg/lpr mice described
in this study. Therefore, it seems likely that the elevated Ig
and autoantibodies resulting from B-cell hyperplasia are
necessary but not sufficient for the development of
autoimmune kidney disease and that enhanced survival of
myeloid and/or T cells is also a requisite factor.
Materials and Methods
Mice. All mice were bred at the Walter and Eliza Hall Institute (WEHI)
and procedures regulated by the WEHI animal ethics committee. To generate
vavP-Mcl-1tg/Faslpr/lpr (hereafter Mcl-1tg/lpr) mice, male vavP-Mcl-1(33) (hereafter
Mcl-1tg) mice37 were bred with female Faslpr/lpr (hereafter lpr) mice.27 Subsequently,
Mcl-1tg/Faslpr/lpr males were bred with Faslpr/lpr females to maintain the mouse
colony. Age- and sex-matched WTand vavP-Mcl-1(33) mice were used as controls.
All mice were on a C57BL/6-WEHI background. To assess pathological impact,
cohorts were aged and sick mice were autopsied at ethical endpoint. Healthy mice
were also analyzed at 8, 14 and 21 weeks of age. Blood and tissue samples were
taken for histology and flow cytometric analysis. Tumorigenicity was tested by
injecting spleen cells from sick lpr (n= 4) or Mcl-1tg/lpr (n= 4) mice intravenously
into syngeneic C57BL/6 mice (2 × 106 cells per recipient).
Haemopoietic tissue composition. Single-cell suspensions were pre-
pared from spleen, thymus, lymph nodes (axillary, brachial, inguinal) and bone marrow.
Red blood cells were removed using 0.168 M ammonium chloride. Peripheral blood
cell counts were enumerated using an ADVIA 2120 analyser (Siemens, Erlangen,
Germany) and organ cell counts enumerated on a Casy Counter (Scharfe, Reutlingen,
Germany). Cell composition was determined by immunostaining and flow cytometry
(LSR I flow cytometer, BD Biosciences, Franklin Lakes, NJ, USA), using FlowJo
Version 9.3.2 (TreeStar, Ashland, OR, USA). Monoclonal antibodies against cell surface
markers were produced and labelled (in-house) with biotin, fluorescein isothiocyanate
(FITC), R-phycoerythrin (PE) or allophycocyanin (APC) unless otherwise indicated.
Antibodies used included: RA3-6B2, anti-B220; YTA3.2.1, anti-CD4; 53.6.7.2, anti-CD8;
1D3, anti-CD19; RB6-8C5, anti-Gr1; 1145-2C11, anti-IgD; 5.1, anti-IgM; MI/70, anti-
Mac1; T3.24.1, anti-Thy1; H57-59, anti-TCRβ; Ter119, anti-erythroid marker; 187.1,
anti-Ig κ light chain (APC-CyTM7 conjugated; BD Biosciences, catalogue #561353);
281-2, anti-CD138 (PE conjugated; BD Biosciences, catalogue #558626). Cells stained
with biotin-labelled antibodies were secondarily stained with PE-CyTM7 streptavidin (BD
Biosciences, catalogue #557598) before flow cytometry. Supplementary Figures S2
and S3 show gating strategies.
Histological analysis. Tissue samples were fixed in 10% formalin, embedded
in paraffin wax, sectioned and stained with haematoxylin and eosin (H&E).
Lymphocyte infiltration of tissues was assessed (blinded) using an Olympus BX43
microscope (Olympus, Tokyo, Japan). Photographs were taken with an Olympus
DP72 camera (Olympus). H&E-stained sections of the kidneys were examined by a
nephrologist (P Hughes) for evidence of GN and scored (blinded) on a scale of 0–4:
0= normal, 1=minor mesangial hypercellularity, 2=moderate glomerular hypercellu-
larity, 3= severe glomerular hypercellularity with thickening of capillary loops,
4= severe glomerular hypercellularity with thickening and obliteration of all capillary
loops and marked distortion of the glomerular tuft or fibrinoid necrosis or crescent
formation. To stain for immune complex deposits, kidneys from WT, Mcl-1tg, lpr or
Mcl-1tg/lpr mice were snap frozen in Tissue-Tek O.C.T. compound (Sakura Finetek
Inc., Torrance, CA, USA), sectioned onto Menzel-Glaser Superfrost Plus slides and
fixed with acetone. Sections were blocked with phosphate-buffered saline (PBS)
supplemented with 2% foetal calf serum (FCS) and stained with FITC-coupled goat
antibodies specific to mouse IgM, IgG or IgA (Southern Biotech, Birmingham, AL,
USA) and counterstained with 4′,6-diamidino-2-phenylindole (DAPI) to label nuclei.
Slides were mounted with Aqua-Poly/Mount (Polyscience Inc., Warrington, PA, USA).
Three-dimensional z-stack images were acquired on a Leica SP8 confocal microscope
Figure 5 Serum Ig levels are elevated inMcl-1tg/lprmice. (a) ELISA quantification of Ig levels (IgA, IgG1, IgG2a, IgG2b, IgG3 and IgM) in sera of 14-week healthy WT (white,
n= 5), Mcl-1tg (light grey, n= 4), lpr (dark grey, n= 6) and Mcl-1tg/lpr (black, n= 6) mice. Bars represent mean± S.E.M. (b) ELISPOT enumeration of the total number of
antibody-secreting cells (ASCs) in the spleen and bone marrow (per femur) of healthy 14-week WT (white, n= 7), Mcl-1tg (light grey, n= 6), lpr (dark grey, n= 6) and Mcl-1tg/lpr
(black, n= 5) mice. Data points represent individual mice with mean±S.E.M indicated. (c) Representative confocal images of snap frozen kidney sections stained with FITC-
labelled antibody for the presence of IgG-, IgM- or IgA-deposition (green) in the glomeruli; nuclei are stained with DAPI (blue). One mouse of each genotype is shown. White
arrows indicate Ig deposition on the glomerular capillary loops. Scale bar= 25 μm. (d) Enumeration of staining patterns observed in snap frozen kidney sections analyzed for the
presence of IgG-, IgM- or IgA- deposition (see also Supplementary Figure S6). Graphs indicate the proportions of WT (n= 2), Mcl-1tg (n= 2), lpr (n= 8) and Mcl-1tg/lpr (n= 4)
kidneys showing no staining of glomeruli (white), staining of Ig deposition on mesangial cells only (grey), or staining of Ig deposition on both glomerular capillary tubules and
mesangial cells (black). *Po0.05, **Po0.01, ***Po0.001, calculated by Student’s T-test with Welch’s correction
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(Leica Microsystems, Wetzlar, Germany) using the galvanometric scanner and a
40 × 1.3N.A. objective with oil. Tile scans of 5 × 5 fields of view were also captured
using the 8 kHz resonant scanner on the confocal and automatically stitched together
with the Leica LAS-X software’s algorithm. The final images were then converted to a
maximum intensity projection view using the Z-Project feature of FIJI.
In vitro cell viability assay. CD4+CD8+ DP thymocytes were sorted using a
MoFlo (Cytomation, Fort Collins, CO, USA) high-speed sorter and then plated in
100 μl of high glucose Dulbecco’s modified Eagle’s media (DME Kelso)
supplemented with 10− 6 M asparagine (Sigma-Aldrich, St. Louis, MO, USA),
50 μM 2-mercaptoethanol (Sigma-Aldrich) and 10% FCS (Gibco, Mulgrave, VIC,
Impact of Mcl-1 overexpression in lpr mice
NS Anstee et al
406
Cell Death and Differentiation
Australia) at a concentration of 50 × 103 cells per well with or without stimulus at a
final concentration of 32 ng/ml Fc-FasL (produced at WEHI using plasmid ps1117
kindly provided by Dr Pascal Schneider, University of Lausanne) or 1 μg/ml
etoposide (Pfizer, West Ryde, NSW, Australia). Cell viability was measured using a
FACSCalibur (BD Biosciences) 0, 4, 12, 24 and 48 h after treatment with a cytotoxic
stimulus by staining with annexin V-Alexa647 (in-house) and propidium iodide (PI;
Sigma-Aldrich). Viability (live cells identified as annexin V–PI–) was calculated
relative to untreated samples to determine the percentage of stimulus-induced
apoptosis and then normalized to viability at 0 h.
Immunoblotting. Western blots were performed according to standard
procedures using protein lysates prepared from whole spleen samples or sorted
cell populations from spleen or bone marrow (sorted using FACSAria, BD
Biosciences) using RIPA buffer (300 mM NaCl, 2% IGEPAL CA-630, 1%
deoxycholic acid, 0.2% SDS, 100 mM Tris-HCl pH 8.0) containing complete ULTRA
protease inhibitors (Roche, Basel, Switzerland) and phenylmethylsulphonyl fluride
(Sigma-Aldrich). Samples were run on NuPAGE Bis-Tris 10% gels (Life
Technologies, Carlsbad, CA, USA) with NuPAGE MOPS SDS running buffer (Life
Technologies) and transferred to nitrocellulose membranes with an iBlot (Life
Technologies). Blots were probed with antibodies to Mcl-1 (clone 19C4-15, WEHI
monoclonal facility), Flag (clone 11F3, WEHI monoclonal facility) and β-actin (clone
AC-74, Sigma, catalogue #A2228), used as a loading control, followed by
secondary staining with horseradish peroxidase (HRP)-conjugated rat or mouse Ig-
specific secondary antibodies (Southern Biotech) and visualized using Luminata
Forte western blot HRP substrate (Merck Millipore, Billerica, MA, USA) on a
ChemiDocTM Touch Imaging System (Bio-Rad, Hercules, CA, USA).
ELISPOT assay. MultiScreen-HA filter plates (Merck Millipore) were coated by
incubation overnight at 4 °C with 2 μg/ml goat anti-mouse IgM/G/A (H+L) antibodies
(Merck Millipore) or 10 μg/ml goat anti-mouse IgA antibodies (Southern Biotech).
Plates were washed before adding 1 × 104 or 1 × 105 red cell-depleted spleen or
bone marrow cells per well in 200 μl Iscove's modified Dulbecco's medium
supplemented with 10% FCS and incubated at 37 °C for 19 h. The plates were
washed before incubation with secondary antibodies diluted in block (PBS with 1%
FCS (Gibco), 0.05% Tween 20 (Sigma) and 0.6% skim milk powder (Devondale,
Brunswick, VIC, Australia)): goat anti-mouse IgG1/IgG2a/IgG2b/IgG3 antibodies
conjugated to HRP or goat anti-mouse IgM antibodies conjugated to HRP or goat
anti-mouse IgA antibodies conjugated to biotin (all Southern Biotech). For
biotinylated antibodies, plates were washed and incubated with streptavidin-HRP
(Southern Biotech) diluted in blocking buffer. After further washing, 100 μl of
substrate solution (250 μg/ml 3-amino-9-ethylcarbazole (Sigma-Aldrich) in 0.05 M
sodium acetate (pH 5.0) and 0.03% H2O2) was added to each well. ELISPOTs were
counted on an ELISPOT reader (Autoimmun Diagnostika GMBH, Strasburg,
Germany).
Serum Igs. Serum Ig levels were determined by ELISA using sheep anti-mouse
Ig antibodies (Silenus Laboratories, Hawthorn, VIC, Australia) and mouse Ig
isotype-specific goat antibodies conjugated with HRP (Southern Biotech) as
previously described.60 Absorbance was read at 405 nm using a VMax microplate
reader (Molecular Devices, Sunnyvale, CA, USA). ANAs were quantitated using
ELISA kits for detecting mouse anti-dsDNA IgG, anti-ssDNA IgG, anti-dsDNA IgM,
anti-ssDNA IgM (Alpha Diagnostics International, San Antonio, TX, USA).
Absorbance was read at 450 nm using a Chameleon plate reader (Hidex,
Broomhill, UK). ANAs were also detected by confocal microscopy using the ANA
Test system (Immuno Concepts, Sacramento, CA, USA) and slides coated with
HEp-2 human epithelial cells, stained according to the manufacturer’s instructions,
as described.60 Images were acquired using an Olympus FV1000 inverted confocal
microscope (Olympus) (60 × 1.4N.A with oil). ANA levels were assessed
semiquantitatively according to the brightness of fluorescence intensity on a scale of
0 to 3+.
Statistical analysis. GraphPad Prism (GraphPad Software Inc., San Diego,
CA, USA) was used to graph and statistically analyze data. Statistical significance
was determined using a two-tailed Student’s T-test with Welch’s correction (assume
unequal variance); P-values o0.05 were considered to be statistically significant.
For analysis of Kaplan–Meier mouse survival curves, significance was determined
using the log-rank (Mantel–Cox) test.
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